SE402915B - Forfarande for framstellning av imidazo(5,1-f)triazinoner med terapeutisk verkan - Google Patents

Forfarande for framstellning av imidazo(5,1-f)triazinoner med terapeutisk verkan

Info

Publication number
SE402915B
SE402915B SE7214358A SE1435872A SE402915B SE 402915 B SE402915 B SE 402915B SE 7214358 A SE7214358 A SE 7214358A SE 1435872 A SE1435872 A SE 1435872A SE 402915 B SE402915 B SE 402915B
Authority
SE
Sweden
Prior art keywords
triazinones
imidazo
procedure
preparation
therapeutic effect
Prior art date
Application number
SE7214358A
Other languages
English (en)
Swedish (sv)
Inventor
S C Garside
D Hartley
L H C Lunts
A W Oxford
Original Assignee
Allen & Hanburys Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allen & Hanburys Ltd filed Critical Allen & Hanburys Ltd
Publication of SE402915B publication Critical patent/SE402915B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075—Two hetero atoms, in positions 3 and 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7214358A 1971-11-19 1972-11-06 Forfarande for framstellning av imidazo(5,1-f)triazinoner med terapeutisk verkan SE402915B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5375071A GB1400999A (en) 1971-11-19 1971-11-19 Imidazo-triazine compounds and their use in therapeutic compositions

Publications (1)

Publication Number Publication Date
SE402915B true SE402915B (sv) 1978-07-24

Family

ID=10468856

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7214358A SE402915B (sv) 1971-11-19 1972-11-06 Forfarande for framstellning av imidazo(5,1-f)triazinoner med terapeutisk verkan

Country Status (18)

Country Link
US (1) US3840537A (fr)
JP (1) JPS563873B2 (fr)
AT (1) AT321923B (fr)
AU (1) AU472127B2 (fr)
BE (1) BE791025A (fr)
CA (1) CA990292A (fr)
CH (1) CH594671A5 (fr)
DE (1) DE2255172A1 (fr)
DK (1) DK138691B (fr)
ES (1) ES408736A1 (fr)
FR (1) FR2160407B1 (fr)
GB (1) GB1400999A (fr)
IE (1) IE37046B1 (fr)
IL (1) IL40686A (fr)
NL (1) NL7215646A (fr)
PH (1) PH9669A (fr)
SE (1) SE402915B (fr)
ZA (1) ZA727532B (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1457873A (en) * 1973-01-04 1976-12-08 Allen & Hanburys Ltd Imidazotriazines
DE2314488C3 (de) * 1973-03-23 1979-01-04 C.H. Boehringer Sohn, 6507 Ingelheim 8-(2,6-Dichlorphenyl)-7-(4-chlorphenyl)-5-oxo-233,8-tetrahydro-imidazo [1,2-a] -s-triazin, Verfahren zu dessen Herstellung und dieses enthaltene Arzneimittel
DE2335193A1 (de) * 1973-07-11 1975-01-30 Hoechst Ag Bis-triazinobenzimidazole und ihre herstellung
US4115572A (en) * 1977-02-03 1978-09-19 American Cyanamid Company Imidazo-[1,5-d]-as-triazin-1(2H)-ones and method of ameliorating asthma
USRE30511E (en) * 1977-02-03 1981-02-10 American Cyanamid Company Imidazo[1,5-d]-as-triazine-4(3H)-ones and thiones
US4107307A (en) * 1977-02-03 1978-08-15 American Cyanamid Company Imidazo [1,5-d]-as-triazine-4(3H)-ones and thiones
DK109578A (da) * 1977-03-25 1978-09-26 Allen & Hanburys Ltd Fremgangsmaade til fremstilling af heterocycliske forbindelser
US4107308A (en) * 1977-10-18 1978-08-15 American Cyanamid Company Imidazo[1,5-d]-as-triazines
US4308384A (en) * 1978-09-18 1981-12-29 Glaxo Group Limited Production of triazinones
HU187474B (en) * 1981-11-18 1986-01-28 Gyogyszerkutato Intezet,Hu Process for producing new spiro-pyrazole-square bracket-1,5-d-square bracket closed-square bracket-1,2,4-square bracket closed-triazine derivatives
US4395547A (en) * 1982-02-10 1983-07-26 American Cyanamid Co. Process for preparing 1-substituted-6-n-propyl-8-methylimidazo[1,5-d]-as-triazin-4(3H)-ones
AU622330B2 (en) * 1989-06-23 1992-04-02 Takeda Chemical Industries Ltd. Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
US6624181B1 (en) * 1997-02-28 2003-09-23 Altana Pharma Ag Synergistic combination
EP2295436A1 (fr) * 1997-11-12 2011-03-16 Bayer Schering Pharma AG 2-Phényl-substitués Imidazotriatinone comme inhibiteurs de la phosphodiesterase V
DE19827640A1 (de) * 1998-06-20 1999-12-23 Bayer Ag 7-Alkyl- und Cycloalkyl-substituierte Imidazotriazinone
JP2002523452A (ja) 1998-08-26 2002-07-30 スミスクライン・ビーチャム・コーポレイション 肺疾患の治療方法
KR100701904B1 (ko) * 1999-08-21 2007-04-02 알타나 파마 아게 Ｐｄｅ 억제제 및 베타 2 아드레날린수용체 작동제의상승적 조합
PL363679A1 (en) * 2001-05-09 2004-11-29 Bayer Healthcare Ag Novel use of 2-phenyl-substituted imidazotriazinones
GB0113344D0 (en) * 2001-06-01 2001-07-25 Bayer Ag Novel heterocycles 3
GB0113343D0 (en) * 2001-06-01 2001-07-25 Bayer Ag Novel Heterocycles 2
DE10135815A1 (de) 2001-07-23 2003-02-06 Bayer Ag Verwendung von 2-Alkoxyphenyl-substituierten Imidazotriazinonen
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
DE602004021363D1 (de) * 2003-04-01 2009-07-16 Smithkline Beecham Corp Imidazotriazin verbindungen zur behandlung von krebserkrankungen
UA89493C2 (uk) 2004-04-02 2010-02-10 Оси Фармасьютикалз, Инк. 6,6-біциклічні кільцеві заміщені гетеробіциклічні інгібітори протеїнкіназ
DE102005001989A1 (de) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenöse Formulierungen von PDE-Inhibitoren
DE102005009240A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
EP1931797A2 (fr) * 2005-09-29 2008-06-18 Bayer HealthCare AG Inhibiteurs pde et combinaisons de ceux-ci pour traiter des troubles urinaires
BRPI0618622A2 (pt) * 2005-11-17 2011-09-06 Osi Pharm Inc composto, composição, e, uso de um composto
KR20100029762A (ko) * 2007-06-13 2010-03-17 바이엘 쉐링 파마 악티엔게젤샤프트 청력 장애 치료용 ｐｄｅ 억제제
CA2752826A1 (fr) 2009-04-20 2010-10-28 OSI Pharmaceuticals, LLC Preparation de c-pyrazine-methylamines
CN103374002B (zh) * 2012-04-19 2015-07-15 山东轩竹医药科技有限公司 磷酸二酯酶-5抑制剂
TW201639851A (zh) * 2015-03-16 2016-11-16 大日本住友製藥股份有限公司 雙環咪唑衍生物
WO2017000276A1 (fr) * 2015-07-01 2017-01-05 Merck Sharp & Dohme Corp. Composés hétérocycliques bicycliques utilisés en tant qu'inhibiteurs de pde2
WO2017204316A1 (fr) * 2016-05-27 2017-11-30 塩野義製薬株式会社 Dérivé de 5-oxo-1,2,4-triazine et composition pharmaceutique correspondante

Also Published As

Publication number Publication date
US3840537A (en) 1974-10-08
AU472127B2 (en) 1976-05-20
IL40686A (en) 1975-12-31
IE37046B1 (en) 1977-04-27
BE791025A (fr) 1973-05-07
PH9669A (en) 1976-02-10
FR2160407B1 (fr) 1975-10-17
DK138691C (fr) 1979-03-26
GB1400999A (en) 1975-07-16
ES408736A1 (es) 1976-03-01
DE2255172A1 (de) 1973-05-24
FR2160407A1 (fr) 1973-06-29
AT321923B (de) 1975-04-25
AU4819172A (en) 1974-05-16
CA990292A (en) 1976-06-01
JPS563873B2 (fr) 1981-01-27
CH594671A5 (fr) 1978-01-13
IE37046L (en) 1973-05-19
IL40686A0 (en) 1972-12-29
DK138691B (da) 1978-10-16
JPS4857993A (fr) 1973-08-14
ZA727532B (en) 1973-07-25
NL7215646A (fr) 1973-05-22

Similar Documents

Publication Publication Date Title
SE402915B (sv) Forfarande for framstellning av imidazo(5,1-f)triazinoner med terapeutisk verkan
SE405604B (sv) Analogiforfarande for framstellning av 1,2,4-triazol-3-karboxamid-1-(beta-d-ribofuranosyl)
SE384211B (sv) Forfarande for framstellning av 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner
SE392269B (sv) Forfarande for framstellning av vissa indanyloxitetrazoler
SE395890B (sv) Forfarande for framstellning av anthelmintiskt verksamma 2-karbalkoxiamino-bensimidazol-5 (6)-fenyletrar
NO137012C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive pyrazolo (1,5-a)-pyrimidiner
SE405599B (sv) Forfarande for framstellning av pyridazinoner med terapeutisk verkan
FI54121C (fi) Foerfarande foer framstaellning av blodtryckssaenkande imidazo-(1,2-a)-imidazoler -pyrimidiner och diazepiner och deras syraadditionssalter
SE396388B (sv) Analogiforfrande for framstellning av 2,3-dihydro-oxo-imidazo-/1,2-a/pyrimidiner
SE395892B (sv) Forfarande for framstellning av piperidyl-bensimidazoliner med terapeutisk verkan
SE398499B (sv) Forfarande for framstellning av 2,4,5,6-tetrahydrocyklopenta/c/purrol-4-karboxamider och -4-tiokarboxamider med terapeutisk verkan
SE386175B (sv) Forfarande for framstellning av 1,4-bis-acylpiperaziner
SE380804B (sv) Anologiforfarande for framstellning av s-triazolo (1,5-a) (1,4)
SE7507887L (sv) Forfarande for framstellning av bensopyranforeningar med terapeutisk verkan.
SE387936B (sv) Forfarande for framstellning av substituerade metoxiaminer
SE398122B (sv) Analogiforfarande for framstellning av pyrazino/1,2-a/indol-2-karboxamidiner
SE390025B (sv) Forfarande for framstellning av 3 alfa-hydroxi-19-5 alfa-pregnan-11,20-dion
SE409866B (sv) Forfarande for framstellning av adenosinderivat
SE380520B (sv) Forfarande for framstellning av 1-cinnamylidenamino-3-bensylidenaminoguanidin
SE393980B (sv) Forfarande for framstellning av 5-(och7-) bensoylindolin-2-oner med terapeutisk verkan
SE395689B (sv) Forfarande for framstellning av vissa angivna bensalacetonamidinohydrazonderivat med antiviral verkan
SE386897B (sv) Forfarande for framstellning av n-acyl-(piperazinoetyl)-pyrazoler
SE394430B (sv) Forfarande for framstellning av indolylalkylaminer med terapeutisk verkan
SE385897B (sv) Forfarande for framstellning av bensoditianpyronderivat med terapeutisk verkan
SE400777B (sv) Forfarande for framstellning av 2,4-diamino-5-bensylpyrimidiner med antibakteriell verkan